LIV-1 Antibody-Drug Conjugate: A Novel Therapeutic Agent for Breast Cancer

被引：0
|
作者：
Smith, L. M. [1 ]
Sussman, D. [1 ]
Nesterova, A. [1 ]
Westendorf, L. [1 ]
Duniho, S. [1 ]
Anderson, M. [1 ]
Mbow, B. [1 ]
Gregoire, A. [1 ]
Hunter, J. [1 ]
Whiting, N. [1 ]
Law, C. L. [1 ]
Benjamin, D. R. [1 ]
机构：
[1] Seattle Genet Inc, Bothell, WA USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P6-15-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-15-16
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study
    Abelman, Rachel Occhiogrosso
    Spring, Laura
    Fell, Geoffrey G.
    Ryan, Phoebe
    Vidula, Neelima
    Medford, Arielle J.
    Shin, Jennifer
    Isakoff, Steven J.
    Moy, Beverly
    Ellisen, Leif W.
    Bardia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] The Emerging Role of the LIV-1 Subfamily of Zinc Transporters in Breast Cancer
    Kathryn M. Taylor
    Helen E. Morgan
    Kathryn Smart
    Normawati M. Zahari
    Sara Pumford
    Ian O. Ellis
    John F. R. Robertson
    Robert I. Nicholson
    Molecular Medicine, 2007, 13 : 396 - 406
  • [33] Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
    Makhlin, Igor
    DeMichele, Angela
    CELL REPORTS MEDICINE, 2022, 3 (06)
  • [34] AN ANTIBODY-DRUG CONJUGATE IS EFFECTIVE IN HER2-POSITIVE BREAST CANCER
    不详
    CANCER DISCOVERY, 2012, 2 (11) : 969 - 969
  • [35] Identifying mutations in ctDNA to predict antibody-drug conjugate response in breast cancer
    Chinea, Luis
    Chan, Isaac
    Chang, Hannah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Radiotherapy and novel antibody-drug conjugates in breast cancer patients
    Ippolito, Edy
    Benincasa, Martina
    Silipigni, Sonia
    Infante, Jessica
    Donato, Marco
    Pantano, Francesco
    Fiore, Michele
    Greco, Carlo
    Molfese, Elisabetta
    Di Donato, Alessia
    Sciommari, Cecilia
    Carnevale, Alessia
    Tonini, Giuseppe
    Ramella, Sara
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S677 - S679
  • [37] Novel antibody-drug conjugates for triple negative breast cancer
    Nagayama, Aiko
    Vidula, Neelima
    Ellisen, Leif
    Bardia, Aditya
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [38] Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer
    Myra F. Barginear
    Veena John
    Daniel R. Budman
    Molecular Medicine, 2012, 18 : 1473 - 1479
  • [39] Antibody-Drug Conjugates for Breast Cancer
    Marme, Frederik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 26 - 36
  • [40] Antibody-drug conjugates in breast cancer
    Zhu, Yinxing
    Song, Yaqi
    Zhou, Xilei
    Zhang, Wenwen
    Luo, Honglei
    CARCINOGENESIS, 2025, 46 (01)
12345